Youdim MB - Search Results

1

Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.

Grünblatt E, Ruder J, Monoranu CM, Riederer P, Youdim MB, Mandel SA. Grünblatt E, et al. Among authors: youdim mb. Neurotox Res. 2018 Apr;33(3):560-568. doi: 10.1007/s12640-017-9843-5. Epub 2017 Dec 7. Neurotox Res. 2018. PMID: 29218503

2

Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron.

Youdim MB, Grünblatt E, Levites Y, Maor G, Mandel S. Youdim MB, et al. Neurotox Res. 2002 Nov-Dec;4(7-8):679-689. doi: 10.1080/1029842021000045507. Neurotox Res. 2002. PMID: 12709306

3

Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.

Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB. Mandel S, et al. Among authors: youdim mb. Ann N Y Acad Sci. 2005 Aug;1053:356-75. doi: 10.1196/annals.1344.031. Ann N Y Acad Sci. 2005. PMID: 16179542 Review.

4

Genomic aspects of sporadic Parkinson's disease.

Riederer P, Youdim MB, Mandel S, Gerlach M, Grünblatt E. Riederer P, et al. Among authors: youdim mb. Parkinsonism Relat Disord. 2008;14 Suppl 2:S88-91. doi: 10.1016/j.parkreldis.2008.04.009. Epub 2008 Jun 27. Parkinsonism Relat Disord. 2008. PMID: 18585078 Review.

5

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes.

Grünblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MB. Grünblatt E, et al. Among authors: youdim mb. J Neural Transm (Vienna). 2004 Dec;111(12):1543-73. doi: 10.1007/s00702-004-0212-1. Epub 2004 Sep 30. J Neural Transm (Vienna). 2004. PMID: 15455214

6

Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Gerlach M, Double KL, Youdim MB, Riederer P. Gerlach M, et al. Among authors: youdim mb. J Neural Transm Suppl. 2006;(70):133-42. doi: 10.1007/978-3-211-45295-0_21. J Neural Transm Suppl. 2006. PMID: 17017520 Review.

7

Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.

Gerlach M, Double KL, Ben-Shachar D, Zecca L, Youdim MB, Riederer P. Gerlach M, et al. Among authors: youdim mb. Neurotox Res. 2003;5(1-2):35-44. doi: 10.1007/BF03033371. Neurotox Res. 2003. PMID: 12832223 Review.

8

Neuroprotective strategies in Parkinson's disease : an update on progress.

Mandel S, Grünblatt E, Riederer P, Gerlach M, Levites Y, Youdim MB. Mandel S, et al. Among authors: youdim mb. CNS Drugs. 2003;17(10):729-62. doi: 10.2165/00023210-200317100-00004. CNS Drugs. 2003. PMID: 12873156 Review.

9

Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway.

Mandel S, Reznichenko L, Amit T, Youdim MB. Mandel S, et al. Among authors: youdim mb. Neurotox Res. 2003;5(6):419-24. doi: 10.1007/BF03033171. Neurotox Res. 2003. PMID: 14715445

10

Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.

Mandel S, Maor G, Youdim MB. Mandel S, et al. Among authors: youdim mb. J Mol Neurosci. 2004;24(3):401-16. doi: 10.1385/JMN:24:3:401. J Mol Neurosci. 2004. PMID: 15655262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters